Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05047198 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial

Study acronym: CARA-VT RCT
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 5 of 18 entries
    • Study description revised
  2. 2 versions Re-verified since Jan 8, 2024, no change to tracked fieldsv5-v6
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of May 15, 2022 to Dec 6, 2022
    • Study sites: 0 to 1
    v4
  4. Start date: Feb 15, 2022 to May 15, 2022v3
  5. Start date: Sep 15, 2021 to Feb 15, 2022
    • Eligibility criteria expanded, about 12 words
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study compares two arms - the current standard of care catheter ablation for Ventricular Tachycardia compared to stereotactic radiotherapy to non-invasively ablate ventricular tachycardia using a novel non-invasive ECG based body surface mapping technology. This allows investigators to identify ventricular tachycardia circuits to target for subsequent radio ablation. To summarize, the current standard of care invasive catheter ablation to the non-invasive radio ablation.
Trial Details
NCT Number NCT05047198
Lead Sponsor Ottawa Heart Institute Research Corporation
Conditions
(from sponsor)		 Ventricular Tachycardia
Related terms Tachycardia, Ventricular
Enrollment 244 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov